Diabetes pay-for-performance program can reduce all-cause mortality in patients with newly diagnosed type 2 diabetes mellitus

This study aimed to examine the effect of a diabetes pay-for-performance (P4P) program on all-cause mortality in patients with newly diagnosed type 2 diabetes mellitus. Using a Taiwanese representative nationwide cohort, we recruited 5478 patients with newly diagnosed type 2 diabetes enrolled in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kung, Fang-Ping, Tsai, Ching-Fang, Lu, Chin-Li, Huang, Li-Chung, Lu, Chieh-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035087/
https://www.ncbi.nlm.nih.gov/pubmed/32049836
http://dx.doi.org/10.1097/MD.0000000000019139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035087/
https://www.ncbi.nlm.nih.gov/pubmed/32049836
http://dx.doi.org/10.1097/MD.0000000000019139

Ejemplares similares